Our Clinical Studies

We design and conduct clinical trials for dietary supplements, cosmetics, and medical devices based on substances compliant with the European Regulation 2017/745 (MDR – Medical Device Regulation), and continuously collect market data to ensure the safety of our products.

We manage and conduct clinical studies on products, leveraging our extensive internal cross-disciplinary expertise. This enables us to collaborate effectively with various stakeholders: participants, ethics committees, competent authorities, scientific and academic societies. We constantly stay updated on increasingly stringent international regulations and guidelines to ensure the highest compliance and quality.

Clinical Study of Asthenic Children

The study of 71 abstinent children showed that the Cresko supplement (iron, royal jelly, glutamine, B vitamins) significantly improved their psychosocial and emotional state. Efficacy correlated positively with age, treatment duration, and weight gain, with no short-term adverse events.

GFI Publishes Clinical Trial on Infant Colic

The clinical trial of Rilefast Ace, a medical device based on simethicone and silicon dioxide, showed a significant reduction in infant colic symptoms. Treated infants experienced less pain and crying, with particularly positive results in cases of greater initial distress.

Clinical Study on Lung Conditions

This clinical study evaluated Broncofurin, an integrative supplement with NAC, Marshmallow, Sundew, Red Poppy, and Vitamin C, aiming to enhance lung function and reduce respiratory symptoms in elderly patients with stable COPD. Findings indicate a significant symptom improvement after 1 and 3 months of administration.

Clinical Study on Lung Conditions

This trial integrates previous research on the effectiveness of the Rilefast CE medical device containing simethicone and silica dioxide in treating infant colic. It evaluates the results via ultrasound to measure intestinal gas content.